Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein A and total human chorionic gonadotropin

American Journal of Perinatology

Volumn 32, Issue 7, 2014, Pages 703-711

  Jelliffe Pawlowski, Laura L ^a,b   Baer, Rebecca J ^a   Currier, Robert J ^a   Lyell, Deirdre J ^c   Blumenfeld, Yair J ^c   El Sayed, Yasser Y ^c   Shaw, Gary M ^c   Druzin, Maurie L ^c  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

early onset severe preeclampsia; first trimester aneuploidy screening; pregnancy associated plasma protein A; total human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER; PAPPA1 PROTEIN, HUMAN;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM SCREENING TEST; NULLIPARA; PARITY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; ADOLESCENT; BLOOD; CASE CONTROL STUDY; METABOLISM; PREGNANCY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84930198082     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1396697     Document Type: Article

References (51)

1. Rudra C. B., Williams M. A. Monthly variation in preeclampsia prevalence: Washington State, 1987-2001. J Matern Fetal Neonatal Med: 2005; 18 5 319 324
2. Khan K. S., Wojdyla D., Say L., Gülmezoglu A. M., Van Look P. F. WHO analysis of causes of maternal death: a systematic review. Lancet: 2006; 367 9516 1066 1074
3. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol: 2009; 33 3 130 137
4. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol: 2013; 122 5 1122 1131
5. Sibai B. M. Publications Committee, Society for Maternal-Fetal Medicine. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol: 2011; 205 3 191 198
6. ACOG Committee on Obstetric Practice; American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Int J Gynaecol Obstet: 2002; 77 1 67 75
7. Steegers E. A., von Dadelszen P., Duvekot J. J., Pijnenborg R. Pre-eclampsia. Lancet: 2010; 376 9741 631 644
8. von Dadelszen P., Magee L. A., Roberts J. M. Subclassification of preeclampsia. Hypertens Pregnancy: 2003; 22 2 143 148
9. Kuc S., Koster M. P., Franx A., Schielen P. C., Visser G. H. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS ONE: 2013; 8 5 e63546
10. Park F. J., Leung C. H., Poon L. C., Williams P. F., Rothwell S. J., Hyett J. A. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol: 2013; 53 6 532 539
11. Duley L., Henderson-Smart D. J., Meher S., King J. F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev: 2007; 2 CD004659
12. Bujold E., Morency A. M., Roberge S., Lacasse Y., Forest J. C., Giguère Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can: 2009; 31 9 818 826
13. Roberge S., Villa P., Nicolaides K., et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther: 2012; 31 3 141 146
14. Dugoff L., Hobbins J. C., Malone F. D., et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol: 2004; 191 4 1446 1451
15. Spencer K., Yu C. K., Savvidou M., Papageorghiou A. T., Nicolaides K. H. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol: 2006; 27 6 658 663
16. Odibo A. O., Zhong Y., Longtine M., et al. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta: 2011; 32 4 333 338
17. Keikkala E., Vuorela P., Laivuori H., Romppanen J., Heinonen S., Stenman U. H. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia. Placenta: 2013; 34 11 1059 1065
18. Cole L. A. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol: 2010; 8 102
19. Kirkegaard I., Uldbjerg N., Oxvig C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand: 2010; 89 9 1118 1125
20. Saito S., Nakashima A. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling. J Reprod Immunol: 2014; 101-102 80 88
21. Towner D., Gandhi S., El Kady D. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. Am J Obstet Gynecol: 2006; 194 6 1676 1681, discussion 1681-1682
22. Yu H., Shen Y. T., Li H. L., Yan Y., Ren M. L., Wang B. The relationship between maternal serum prenatal screening combined with epidemiological study and early onset preeclampsia. Arch Gynecol Obstet: 2014; 289 4 749 753
23. Fitzgerald B., Levytska K., Kingdom J., Walker M., Baczyk D., Keating S. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta: 2011; 32 4 339 345
24. Kazerouni N. N., Currier B., Malm L., et al. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol: 2009; 114 1 50 58
25. Currier R., Wu N., Van Meter K., Goldman S., Lorey F., Flessel M. Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services. Prenat Diagn: 2012; 32 11 1077 1083
26. Jelliffe-Pawlowski L. L., Shaw G. M., Currier R. J., et al. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers. Am J Obstet Gynecol: 2013; 208 6 492.e1 492.e11
27. American Medical Association International Classification of Diseases; Physician, Ninth Revision Clinical Modification. 9th ed. Chicago, IL American Medical Association: 2008
28. Ong C. Y., Liao A. W., Spencer K., Munim S., Nicolaides K. H. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG: 2000; 107 10 1265 1270
29. Spencer K., Yu C. K., Cowans N. J., Otigbah C., Nicolaides K. H. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn: 2005; 25 10 949 953
30. Spencer K., Cowans N. J., Chefetz I., Tal J., Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol: 2007; 29 2 128 134
31. Than N. G., Romero R., Hillermann R., Cozzi V., Nie G., Huppertz B. Prediction of preeclampsia - a workshop report. Placenta: 2008; 29 (Suppl A): S83 S85
32. Poon L. C., Maiz N., Valencia C., Plasencia W., Nicolaides K. H. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol: 2009; 33 1 23 33
33. Myatt L., Clifton R. G., Roberts J. M., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol: 2012; 119 6 1234 1242
34. Goetzinger K. R., Singla A., Gerkowicz S., Dicke J. M., Gray D. L., Odibo A. O. Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG. Prenat Diagn: 2010; 30 12-13 1138 1142
35. Meekins J. W., Pijnenborg R., Hanssens M., McFadyen I. R., van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol: 1994; 101 8 669 674
36. Zhou Y., Damsky C. H., Fisher S. J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest: 1997; 99 9 2152 2164
37. Egbor M., Ansari T., Morris N., Green C. J., Sibbons P. D. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG: 2006; 113 5 580 589
38. Cole L. A. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol: 2009; 7 8
39. Meloni P., D'Angeli I., Piazze J., et al. First trimester PAPP-A levels associated with early prediction of pregnancy induced hypertension. Hypertens Pregnancy: 2009; 28 4 361 368
40. Brouillet S., Hoffmann P., Chauvet S., et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci: 2012; 69 9 1537 1550
41. Lee C. L., Chiu P. C., Hautala L., et al. Human chorionic gonadotropin and its free β-subunit stimulate trophoblast invasion independent of LH/hCG receptor. Mol Cell Endocrinol: 2013; 375 1-2 43 52
42. Odibo A. O., Patel K. R., Spitalnik A., Odibo L., Huettner P. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol: 2014; 34 3 186 191
43. Costa S. L., Proctor L., Dodd J. M., et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta: 2008; 29 12 1034 1040
44. Askie L. M., Duley L., Henderson-Smart D. J., Stewart L. A. PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet: 2007; 369 9575 1791 1798
45. Levine R. J., Maynard S. E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med: 2004; 350 7 672 683
46. Wortelboer E. J., Koster M. P., Cuckle H. S., Stoutenbeek P. H., Schielen P. C., Visser G. H. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG: 2010; 117 11 1384 1389
47. Hawkins T. L., Roberts J. M., Mangos G. J., Davis G. K., Roberts L. M., Brown M. A. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG: 2012; 119 4 484 492
48. Catov J. M., Ness R. B., Kip K. E., Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol: 2007; 36 2 412 419
49. Hernández-Díaz S., Toh S., Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ: 2009; 338 b2255
50. Audibert F., Boucoiran I., An N., et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol: 2010; 203 4 383.e1 383.e8
51. Matsuda Y., Hayashi K., Shiozaki A., Kawamichi Y., Satoh S., Saito S. Comparison of risk factors for placental abruption and placenta previa: case-cohort study. J Obstet Gynaecol Res: 2011; 37 6 538 546